Categoría: news

A collaborative effort among colleagues from academia, including EurOPDX and INFRAFRONTIER members, as well as industry, has successfully achieved the publication of a consensus statement about refinement in murine models in Nature Protocols. An editorial on the article was also published. Read it HERE

If you are interested in transnational research and preclinical models, please join us in Barcelona, from October 21st to the 23rd. Organized by VHIO, and supported by all EurOPDX members, the workshop will cover the following scientific sessions: Registration is open HERE

Four heavyweight keynote speakers have confirmed their participation. Please save the dates for joining us in October (21-23) in Barcelona. 4th EurOPDX Workshop Barcelona, Vall d’Hebron Institute of Oncology (VHIO), 21-23 Oct. 2024 “Relevance of pre-clinical models in oncology research” Session 1. 21 Oct. Tumour plasticity and therapy resistance. Eva González, CNIO Session 2. 22… Seguir leyendo The 4th EurOPDX Worshop agenda is taking shape

The workshop will be a fully in-person meeting. It will be held on 21-23 October 2024 at the Vall d’Hebron Institute of Oncology (VHIO). The scientific programme is under preparation. We will keep a capacity of maximum 100 attendees to foster discussions and interactions. It’s also a unique opportunity for early-stage researchers to present their… Seguir leyendo PLEASE SAVE THE DATE FOR THE 4TH EUROPDX WORKSHOP. REGISTRATION WILL COME SOON!

CONSERVATION OF COPY NUMBER PROFILES DURING ENGRAFTMENT AND PASSAGING OF PATIENT-DERIVED CANCER XENOGRAFTS Cancer is one of the major causes of death in Europe. Therefore identification, validation and optimisation of therapeutic strategies to improve survival and quality of life of cancer patients still represent a major public health challenge. Before they can be evaluated in… Seguir leyendo EUROPDX AND PDXNET CONSORTIA PUBLISH A MILESTONE PAPER ON PDX RELIABILITY